ART4 and influenza: The currently licensed vaccines, including inactivated and attenuated influenza vaccines, induce protection mainly by eliciting neutralizing antibodies (NAbs) against the major glycoprotein, hemagglutinin (HA), of influenza virus (Vogel and Manicassamy, 2020).